L
Lightship
Provides enterprise-level services conducting direct-to-patient (DtP) clinical trials
About Lightship
Lightship Solutions revolutionizes the traditional clinical trial model by making clinical research accessible to the 94% of people who cannot participate in conventional trials. The company specializes in Direct to Patient (DtP) clinical trials, partnering with pharmaceutical companies to deliver comprehensive services from patient recruitment to study completion. Lightship's dedicated patient engagement team identifies qualified study participants, while their direct-to-home services ensure that supplies and medications are delivered, and in-home nursing visits are managed efficiently. Lightship's proprietary mobile patient application serves as a central hub for study activities, enhancing the patient experience and streamlining monitoring processes. This electronic platform enables remote monitoring, resulting in better quality data and lower costs. The company also provides investigators, research nurses, and study coordinators to conduct visits, ensuring expedited timelines and streamlined operations. Lightship operates in the clinical research market, primarily serving pharmaceutical companies looking to conduct efficient and patient-centric clinical trials. The business model focuses on providing end-to-end DtP clinical trial services, making money through partnerships and service fees. Keywords: Direct to Patient, clinical trials, patient recruitment, home-based services, remote monitoring, pharmaceutical partnerships, mobile application, in-home nursing, expedited timelines, streamlined operations.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2018
- Headquarters
- El Segundo, United States
- Employees
- 56
- Open positions
- 5
- Dealroom signal
- 62.3/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Clinical, Tech for Biotech and Pharma, Hard Tech
- Client focus
- b2b
- Investment activity
- 2 companies, latest Feb 2026
- Capital deployed
- —
- Preferred round
- MERGER
Latest news
Press, funding announcements and product moves mentioning Lightship.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| MERGEROther financing | Jul 2025 | $0 | — | Circuit Clinical | ↗ |
| LATE VCOther financing | Feb 2024 | $136M | $542M | Undisclosed | ↗ |
Growth signals
Latest recorded traffic for Lightship is 180 monthly website visits, down 95.4% over the last three months. Lightship's team grew 5.7% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Veda Clinical TrialsBoston, United StatesExpanding clinical trials to local communities, enhancing access to cutting-edge therapies and boosting organizational income
→
Circuit ClinicalBuffalo, United StatesAn Integrated Research Organization driven to transform the experience of finding and participating in clinical trials
$116Mvaluation
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
Khosla Ventures
McKesson Ventures
Define Ventures
Brook Byers
Series B and later1 investor entered at this stage
Time Ventures
Other known investors1 additional known investor
Circuit Clinical
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Lightship on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Lightship’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.





